I
Iterative Health
AI-powered clinical research site network
About Iterative Health
Iterative Health, formerly Iterative Scopes, is a healthcare technology and services company that works to speed up clinical research by building a multispecialty network of research sites embedded in everyday clinical care. The company was spun out of the Massachusetts Institute of Technology in 2017 by founder and CEO Jonathan Ng, and it has headquarters in Cambridge, Massachusetts, and New York. It began by applying computer vision to gastrointestinal endoscopy and developed SKOUT, an FDA-cleared AI system that helps physicians detect polyps during colonoscopy.
Today the company's focus is on clinical trial execution. Iterative Health partners with physician practices and provider organisations and supports them with centralised operations, expert research staff, proprietary AI technology and clinical trial expertise, so that practices can run studies alongside patient care. The model uses AI to accelerate trial enrolment, addressing an industry where more than half of research sites enrol one or fewer patients per study and most trials miss their enrolment targets on time.
For pharmaceutical, biotech, medical device companies and contract research organisations, the network offers centralised access to a large group of experienced research sites and diverse patient populations. Iterative Health's global network includes more than 100 research sites across North America, Europe, India and Australia, and it works with more than 40 sponsor and CRO partners, with reported gains in site activation speed and patient enrolment rates in inflammatory bowel disease trials.
The company's roots are in gastroenterology and hepatology, where it collaborates with provider organisations such as GI Alliance and OneGI. It is expanding into further therapeutic areas, including cardiology through a partnership with U.S. Heart & Vascular, and obesity.
Source: Dealroom company dataOpen roles
Iterative Health in the Cambridge ecosystem
The Iterative Health office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed3 investors entered at this stage
Wavemaker Partners
Tau Ventures
P5 Health Ventures
Series A11 investors entered at this stage
Plug and Play
Obvious Ventures
Lee Shapiro
Eli Lilly
Nat Turner
Zach Weinberg
Johnson & Johnson Innovation
Breyer Capital
Seae Ventures
Insight Partners
Clearlake Capital Group
Series B and later4 investors entered at this stage
Insight Partners
Plug and Play- CGClearlake Capital Group
- MTMassachusetts Institute of Technology
Source: Dealroom Talent Intelligence.
Patents
6 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
See Iterative Health on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.
Proximal Ventures closes $27.5M debut fund for AI in pharma